FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/06/2026
Voltar para busca
Dado oficial do USPTO
ROUKEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
11/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
26/11/2024
Data de registro
10/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2026
Última transação
11/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Antibody Analytics Limited
Representantes
Alexandra MacKay Stites & Harbison PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and science; chemicals and reagents for scientific or medical research purposes; chemical preparationssubstances and reagents for analysis in laboratoriesnot for medical or veterinary purposes; diagnostic preparationsnot for medical or veterinary purposes; reagents used for research purposesin particularfor medical research; reagents used for chemical analysesnot for medical or veterinary purposes; scientific reagentsnot for medical or veterinary purposes; chemicals for scientific and research use in the field of immunology; reagents used for scientific and research purposes in the field of immunoserology; diagnostic and testing reagents for scientific usenot for medical or veterinary purposes; immunoassay reagentsother than for medical use; laboratory chemicals and reagents for scientific use and medical research; biochemical reagents used for non-medical purposes; biochemicals being monoclonal antibodies used for non-medical purposes; immunogensimmunoglobulinsantibodiespeptides and proteins for scientific and medical research services; biological activatorspreparations for clinical or medical laboratory use; biological preparations for use as assay samples for research analysis purposes in the field of medical research; reagents for use in scientific apparatus for chemical or biological analysis; biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays used for non-medical purposes; diagnostic preparations for scientific or research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs used for non-medical purposes; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use for non-medical purposes; reagents for scientific and research use; assays and reagents for use in genetic research; cell culture reagents for scientific and research use; protein for industrial use; protein in raw material form for scientific and medical research; assays for research purposes; biochemicalspolypeptides for in vitro research use; biochemicalsDNARNA and oligonucleotides for in vitro research use; cells for scientific and research use; immune cells for scientific and research use; T cells for scientific and research use; primary cells for scientific and research use; immortalised cells for scientific and research use; biological tissuebloodstem cellsdisease state tissuehealthy donor tissuehealthy donor bloodhuman biopsy tissueumbilical cords and placentas for scientific and medical research use
Classe 5
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; biological preparations for medical purposesbiological preparations for the diagnoses and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; large molecules for medical purposes being chemical reagents for medical purposes; biological tissue cultures for medical purposes; biological tissue cultures for medical use; diagnostic preparations for medical purposesbiological tissue; biological preparations for the treatment of cancer; biological preparations for use in cell cultures for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases; biological and chemical preparations and reagents for medical or veterinary use; antiserums for diagnostic purposes for diagnoses of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; diagnostic reagents for medical use; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents and contrast media for medical use; diagnostic agentspreparations and substances for medical purposes; medical diagnostic reagents and assays for testing body fluids for microorganisms; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; antibodies for medical purposes; in-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; reagents for medical use; chemical reagents for medical purposes; reagents for use in medical genetic testing; enzymes for medical purposes; cells for medical or clinical use; culture media for cultivating human cells and microorganism cells for medical purposes; immunoassay reagents for medical use; assay platforms for medical use for detecting and analysing proteinsnucleic acidssmall moleculescellspathogens and lipids; immunology assays for medical use for detecting and analysing proteinsnucleic acidssmall moleculescellspathogens and lipids; antigens for medical use; antiviral T cells for medical use; human immune cellsin particular T cellsfor medical or clinical purposes; human primary cells for medical and clinical use; immortalised human cells for medical and clinical use; target antigens for medical use; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disorders for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; vaccine preparations; therapeutic vaccines
Classe 42
Scientific and medical research and development services for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicotologicrespiratoryneurologicalgastrointestinalpancreaticnephrologicmusculoskeletalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; medical research laboratory services; research and development services in the field of antibodies and antibody technology; advisory services relating to the development of chemical reagents; scientific and industrial research services in the fields of biotechnologypharmaceuticalsimmunologycell engineeringimmunoassays and pharmacogenetics; laboratory services namelyresearchanalysischaracterising and development of therapeutic proteins and human antibodies; development and design of scientific analytical testing methodologies; medical and scientific research into new drug candidates; industrial analysis and research servicesin particular for selectingcharacterising and preparing immunoglobulinsantibodies or parts thereof; research and development services in the field of immunology; DNA sequencing services being identification of immunogenic sequences and peptides; sequence discovery services in the nature of DNA sequencing technology research; medical and scientific immunotoxicology research and analysis services; medical immunogenicity research and analysis services; pharmaceutical drug development services; development of gene-based medicines; research and development of vaccines and medicines; biological cloning services; biological research and analysis; biological drug development services; laboratory research services relating to pharmaceuticals; providing laboratory research services in the field of biopharmaceuticals; chemicalbiochemicalbiological and bacteriological research and analysis; medical and scientific research and development services in the field of molecular science; medical and scientific analysis services in the field of molecular biology and molecular genetics; diagnostic services in the field of immunology; providing reagent sample testing and diagnostic services for others for scientific research purposes; scientific consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; providing information about medical research in the fields of biopharmaceuticalsimmunologycell engineering and immunoassays; consulting services for others in the field of designplanningimplementation project management of scientific research and clinical trials; custom design and development of chemical reagents and biochemical assays; scientific research in the field of genetics and genetic engineering; genetic sequencing analysis services for scientific and medical research purposes; medical and scientific research services analysing the safety and efficacy of new pharmaceuticals; research in the field of cell engineering technology; cell engineering servicesnamely cell suppression and cell activation; medical and scientific researchdevelopmentengineering and testing services in the fields of bioanalytical assaysassay development and antigen binding; medical and scientific researchdevelopmentengineering and testing services in the fields of immunotherapiesantibody-based molecules and targeted protein degraders; medical and scientific researchdevelopmentengineering and testing services in the fields of molecular biologybiophysicsDNA replication and replication of immune cell interaction in the tumour microenvironment; medical and scientific researchdevelopmentengineering and testing services in the field of biopharmaceutical modulating therapeutics; compiling and analysing data for research purposes in the field of medical science and medical consultancy; authentication of data in the field of immunology; cell culture services for scientific and research purposesfor others; DNA sequencing technology research; medical and scientific researchdevelopmentengineering and testing services in the fields of immunopharmaceuticalsvaccines and oncology; consultancyinformation and advisory services relating to all of the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/01/2026
PUBO
PUBLISHED FOR OPPOSITION
20/01/2026
GPNX
NOTIFICATION PROCESSED BY IB
15/01/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/01/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/12/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
17/12/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/12/2025
GNFR
FINAL REFUSAL E-MAILED
16/12/2025
CNFR
FINAL REFUSAL WRITTEN
16/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/11/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/08/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/08/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/08/2025
RFNT
REFUSAL PROCESSED BY IB
02/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/07/2025
RFRR
REFUSAL PROCESSED BY MPU
15/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/05/2025
CNRT
NON-FINAL ACTION WRITTEN
22/05/2025
DOCK
ASSIGNED TO EXAMINER
19/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/05/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/05/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ROUKEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.